Overview. Brain death is defined as the irreversible loss of function of the brain, including the brainstem. Brain death from primary neurologic disease usually is caused by severe head injury or aneurysmal subarachnoid hemorrhage. In medical and surgical intensive care units, however, hypoxic-ischemic brain insults and fulminant hepatic failure may result in irreversible loss of brain function. In large referral hospitals, neurologists make the diagnosis of brain death 25 to 30 times a year.
mm Hg or PCO, increase is <20 mm Hg over baseline normal Pco,, the result is indeterminate, and a n additional confirmatory test can be considered. 
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Quality Standards
DEFINITIONS
Classification of evidence
Class I. Evidence provided by one or more well-designed, randomized, controlled clinical trials.
Class 11. Evidence provided by one or more well-designed clinical studies such as case-control and cohort studies.
Class 111. Evidence provided by expert opinion, nonrandomized historical controls, or one or more case reports.
Strength of recommendations
Standards. Generally accepted principles for patient management that reflect a high degree of clinical certainty (ie, based on class I evidence or, when circumstances preclude randomized clinical trials, ovenvhelming evidence from class I1 studies that directly addresses the question a t hand or from decision analysis that directly addresses all the issues).
Guidelines.
Recommendations for patient management that may identify a particular strategy or range of management strategies and that reflect moderate clinical certainty (ie, based on class I1 evidence that directly addresses the issue, decision analysis that directly addresses the issue, or strong consensus of class I11 evidence).
Practice options or advisories. Strategies for patient management for which clinical certainty is lacking (ie, based on inconclusive or conflicting evidence or opinion).
Practice parameters. Results, in the form of one or more specific recommendations, from a scientifically based analysis of a specific clinical problem.
This statement is provided as an educational service of the American Academy of Neurology. It is based on an assessment of current scientific and clinical information. It is not intended to include all possible proper methods of care for a particular neurologic problem or all legitimate criteria for choosing to use a specific procedure. Neither is it intended to exclude any reasonable alternative methods. The AAN recognizes that specific decisions on patient care are the prerogative of the patient and the physician caring for the patient and are based on all the circumstances involved. Regardless of the conclusions of this statement, the Quality Standards Subcommittee of the AAN recognizes the need to comply with state law.
